Roivant Sciences
(NASDAQ) ROIV
Roivant Sciences Financials at a Glance
Market Cap
$18.98B
Revenue (TTM)
$13.31M
Net Income (TTM)
$809.24M
EPS (TTM)
$-1.17
P/E Ratio
-22.70
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$26.52
Volume
121,509
Open
$27.37
Price
$26.52
Volume
121,509
Open
$27.37
Previous Close
$26.52
Daily Range
$26.48 - $27.48
52-Week Range
$8.73 - $30.33
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$26.52
Volume
121,509
Open
$27.37
Previous Close
$26.52
Daily Range
$26.48 - $27.48
52-Week Range
$8.73 - $30.33
ROIV News
ROIV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Roivant Sciences
Industry
Biotechnology
Sector
Health CareEmployees
750
CEO
Matthew Gline
Website
www.roivant.comHeadquarters
London, SW1Y 4LB, GB
ROIV Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-91%
Net Income Margin
-61%
Return on Equity
-17%
Return on Capital
-24%
Return on Assets
-15%
Earnings Yield
-4.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.98B
Shares Outstanding
715.70M
Volume
121.51K
Short Interest
0.00%
Avg. Volume
6.36M
Financials (TTM)
Gross Profit
$28.14M
Operating Income
$1.00B
EBITDA
$1.10B
Operating Cash Flow
$839.45M
Capital Expenditure
$4.60M
Free Cash Flow
$844.05M
Cash & ST Invst.
$4.89B
Total Debt
$100.17M
Roivant Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.00M
-77.8%
Gross Profit
$1.30M
-85.2%
Gross Margin
64.98%
N/A
Market Cap
$18.98B
N/A
Market Cap/Employee
$20.90M
N/A
Employees
908
N/A
Net Income
$265.89M
-257.0%
EBITDA
$289.68M
-6.7%
Quarterly Fundamentals
Net Cash
$4.32B
-14.3%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$197.01M
+117.7%
Short Term Debt
$10.44M
+6.1%
Return on Assets
-15.49%
N/A
Return on Invested Capital
-23.95%
N/A
Free Cash Flow
$191.55M
+8.4%
Operating Cash Flow
$196.48M
+5.2%